Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Corless

Showing results (81-90 of 208) with videos related to

Pageof 21
Sort By:
American Journal of Clinical Pathology|October 22, 2015
Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumorsDeepa T Patil, Shuang Ma, Mai Konishi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 20, 2021
Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy aloneThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
Cancer Research|October 3, 2003
Absence of BRAF and NRAS mutations in uveal melanomaFrank Cruz, Brian P Rubin, David Wilson, et al.
Journal of Surgical Oncology|June 26, 2024
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, et al.
The Journal of Molecular Diagnostics : JMD|January 10, 2016
A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation SequencingCarol Beadling, Abigail I Wald, Andrea Warrick, et al.
Annals of Surgical Oncology|July 13, 2022
Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal TumorsThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
Annals of Surgical Oncology|May 10, 2021
Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal TumorThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
Surgery|June 6, 2021
Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role?Thomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
BMC Medical Genetics|September 30, 2015
SDHC methylation in gastrointestinal stromal tumors (GIST): a case reportMilena Urbini, Annalisa Astolfi, Valentina Indio, et al.
Neuropathology and Applied Neurobiology|December 9, 2020
Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 MutationMatthew D Wood, Tanaya Neff, Joshua P Nickerson, et al.
Pageof 21

Showing results (81-90 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Clinical Pathology|October 22, 2015
Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumorsDeepa T Patil, Shuang Ma, Mai Konishi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 20, 2021
Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy aloneThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
Cancer Research|October 3, 2003
Absence of BRAF and NRAS mutations in uveal melanomaFrank Cruz, Brian P Rubin, David Wilson, et al.
Journal of Surgical Oncology|June 26, 2024
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, et al.
The Journal of Molecular Diagnostics : JMD|January 10, 2016
A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation SequencingCarol Beadling, Abigail I Wald, Andrea Warrick, et al.
Annals of Surgical Oncology|July 13, 2022
Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal TumorsThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
Annals of Surgical Oncology|May 10, 2021
Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal TumorThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
Surgery|June 6, 2021
Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role?Thomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.
BMC Medical Genetics|September 30, 2015
SDHC methylation in gastrointestinal stromal tumors (GIST): a case reportMilena Urbini, Annalisa Astolfi, Valentina Indio, et al.
Neuropathology and Applied Neurobiology|December 9, 2020
Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 MutationMatthew D Wood, Tanaya Neff, Joshua P Nickerson, et al.
Pageof 21